| __timestamp | Bio-Techne Corporation | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 45967000 |
| Thursday, January 1, 2015 | 40853000 | 114737000 |
| Friday, January 1, 2016 | 45187000 | 183204000 |
| Sunday, January 1, 2017 | 53514000 | 231644000 |
| Monday, January 1, 2018 | 55329000 | 293998000 |
| Tuesday, January 1, 2019 | 62413000 | 357355000 |
| Wednesday, January 1, 2020 | 65192000 | 412084000 |
| Friday, January 1, 2021 | 70603000 | 497153000 |
| Saturday, January 1, 2022 | 87140000 | 705789000 |
| Sunday, January 1, 2023 | 92493000 | 648449000 |
| Monday, January 1, 2024 | 96664000 |
Infusing magic into the data realm
In the dynamic world of biotechnology, research and development (R&D) spending is a critical indicator of innovation and future growth. Over the past decade, Bio-Techne Corporation and Ultragenyx Pharmaceutical Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Bio-Techne's R&D expenses grew steadily, increasing by approximately 212%, reflecting a consistent commitment to innovation. In contrast, Ultragenyx's R&D spending surged by over 1,300% during the same period, peaking in 2022. This dramatic rise underscores Ultragenyx's aggressive pursuit of groundbreaking therapies. However, data for 2024 is missing for Ultragenyx, leaving a gap in the trend analysis. As these companies continue to navigate the competitive biotech landscape, their R&D investments will likely play a pivotal role in shaping their future success.
R&D Spending Showdown: Merck & Co., Inc. vs Ultragenyx Pharmaceutical Inc.
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Bio-Techne Corporation
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Ultragenyx Pharmaceutical Inc.
Research and Development Expenses Breakdown: United Therapeutics Corporation vs Bio-Techne Corporation
Dr. Reddy's Laboratories Limited or Bio-Techne Corporation: Who Invests More in Innovation?
Analyzing R&D Budgets: Bio-Techne Corporation vs Geron Corporation
Comparing Innovation Spending: Bio-Techne Corporation and Galapagos NV
Analyzing R&D Budgets: Bio-Techne Corporation vs Taro Pharmaceutical Industries Ltd.
R&D Spending Showdown: Lantheus Holdings, Inc. vs Ultragenyx Pharmaceutical Inc.
Research and Development Expenses Breakdown: Verona Pharma plc vs Ultragenyx Pharmaceutical Inc.
Comparing Innovation Spending: Ultragenyx Pharmaceutical Inc. and Geron Corporation
Analyzing R&D Budgets: Ultragenyx Pharmaceutical Inc. vs MiMedx Group, Inc.